Freeze-Drying of Pharmaceuticals in Vials Nested in a Rack System-Part I: Freezing Behaviour.
cooling rate
cryopreservation
freeze-drying
freezing
heat transfer
lactate dehydrogenase
proteins
rack system
sucrose
tubing vials
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
14 Feb 2023
14 Feb 2023
Historique:
received:
18
12
2022
revised:
06
02
2023
accepted:
11
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The distribution of biopharmaceuticals often requires either ultra-cold conditions or lyophilisation. In both cases, the drug product is frozen and, thus, exposed to similar stress conditions, which can be detrimental to its quality. However, these stresses can be inhibited or mitigated by a suitable formulation and/or an appropriate freezing design. This paper addresses how the key freezing parameters, i.e., ice nucleation temperature and cooling rate, impact the freezing behaviour of a sucrose-based formulation. The analysis included two loading configurations, vials directly resting on the shelf and nested in a rack system. The loading configuration affected the product freezing rate and the ice nucleation temperature distribution, resulting in larger ice crystals in the case of vials nested in a rack system. SEM micrographs and specific surface area measurements confirmed the different product morphology. Eventually, the different product morphology impacted the bioactivity recovery of lactate dehydrogenase.
Identifiants
pubmed: 36839958
pii: pharmaceutics15020635
doi: 10.3390/pharmaceutics15020635
pmc: PMC9960346
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Control Release. 2011 Jun 30;152(3):349-55
pubmed: 21371510
J Pharm Sci. 1996 Dec;85(12):1325-30
pubmed: 8961147
J Pharm Sci. 2001 Jul;90(7):860-71
pubmed: 11458335
Biophys J. 1996 Feb;70(2):971-6
pubmed: 8789114
J Phys Chem B. 2008 May 15;112(19):5961-7
pubmed: 18181599
J Pharm Sci. 2018 Mar;107(3):824-830
pubmed: 29074380
Crit Rev Biochem Mol Biol. 1990;25(4):281-305
pubmed: 2225910
J Microsc. 1986 Jul;143(Pt 1):89-102
pubmed: 3531522
J Pharm Sci. 2020 Jul;109(7):2116-2130
pubmed: 32240686
J Pharm Sci. 2021 Mar;110(3):1219-1226
pubmed: 33069707
J Pharm Sci. 2018 Jun;107(6):1586-1596
pubmed: 29432761
Int J Pharm. 2022 Feb 5;613:121276
pubmed: 34767908
J Biochem. 1997 Aug;122(2):395-401
pubmed: 9378719
Eur J Pharm Biopharm. 1998 May;45(3):249-57
pubmed: 9653629
Eur J Pharm Biopharm. 2011 Jun;78(2):248-63
pubmed: 21426937
J Pharm Sci. 1999 Dec;88(12):1354-61
pubmed: 10585234
Pharm Res. 1991 Nov;8(11):1360-4
pubmed: 1798670
J Pharm Sci. 2021 Mar;110(3):1323-1336
pubmed: 33275993
Pharm Dev Technol. 2020 Sep;25(7):823-831
pubmed: 32367756
Pharm Dev Technol. 2007;12(5):505-23
pubmed: 17963151
Eur J Pharm Biopharm. 2018 Aug;129:58-65
pubmed: 29787801
J Am Chem Soc. 2020 Mar 25;142(12):5722-5730
pubmed: 32122128
Int J Pharm. 2022 Sep 25;625:122051
pubmed: 35907555
Eur J Pharm Biopharm. 2020 Mar;148:148-159
pubmed: 31953190
Pharm Res. 2022 Oct;39(10):2597-2606
pubmed: 35925479